Reports of infections from travelers continue to provide an important indicator to unrecognized disease exposures as well as infections moving into new populations at risk. The function of travelers as sentinels for imported diseases has been extensively discussed.[7] Sentinel surveillance networks such as GeoSentinel[4] and TropNetEurop[8] play a valuable role in providing data on travel-associated exposures to schistosomiasis as well as on demographic characteristics of infected individuals. While Schistosoma mansoni click here and Schistosoma
haematobium are the most common species involved in African schistosomiasis, in Asia, Schistosoma japonicum and Schistosoma mekongi are the predominant species found to cause disease. China has been endemic for S. japonicum during much of the past century, with over 1.6 million persons
estimated to be infected in the first nationwide survey conducted in 1989,[9] but with a strong national control program, the number of infected individuals was reduced by over 40%, to approximately 860,000 in the second nationwide survey in 1995.[10] In contrast, the third nationwide survey in 2004 showed that human infection rates had increased by 4% in areas of ongoing transmission, although overall, a 16% reduction to 720,000 infections was reported in the seven provinces considered to be still endemic, namely Hunan, Hubei, Jiangxi, Anhui, Yunnan, Sichuan, and Jiangsu.[11] Despite this experience with locally prevalent S. japonicum, Chinese clinicians are less familiar with schistosomiasis acquired buy Torin 1 from distant destinations. Schistosoma haematobium infections have rarely been reported in Asia, with most sporadic cases occurring among returning Japanese travelers.[12] In this issue, Wang[13] and colleagues report two imported cases of S. haematobium which occurred
among Chinese expatriate workers who lived in Tanzania and Angola. This report is of great interest because it indicates new populations potentially at risk because of changing patterns of travel from the emerging economies of Asia. Both men were long-term expatriates who had worked in Africa, but presented after returning home to Henan, China. Both cases had initial missed diagnoses; the first case received 4 months of tuberculosis Resveratrol treatment with isoniazid and pyrazinamide, and the second patient underwent surgical resection for a presumed bladder tumor, before the appropriate diagnosis and treatment were finally arrived at. Schistosoma haematobium infection may be asymptomatic, but clinical presentations include acute itch within 24 hours, systemic illness within several weeks, and urinary symptoms 3–6 months after infection. The diagnosis of urinary schistosomiasis may be confirmed by microscopic examination of urine or histology from clinical samples, although the sensitivity of microscopy is generally lower compared to serologic testing.